Detalhe da pesquisa
1.
Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.
Breast Cancer Res
; 24(1): 63, 2022 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153537
2.
Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.
Breast Cancer Res
; 23(1): 82, 2021 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344433
3.
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer.
Breast Cancer Res
; 22(1): 87, 2020 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32787886
4.
Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer.
Clin Cancer Res
; 29(10): 1952-1968, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862086
5.
Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions.
Nat Commun
; 12(1): 6012, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650042
6.
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer.
Clin Epigenetics
; 13(1): 226, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922619
7.
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.
Nat Med
; 27(2): 310-320, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462444
8.
Development and validation of a targeted gene sequencing panel for application to disparate cancers.
Sci Rep
; 9(1): 17052, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745186
9.
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.
NPJ Precis Oncol
; 3: 21, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31482136
10.
A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes.
Nat Commun
; 9(1): 2311, 2018 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29899353
11.
Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor.
J Nucl Med
; 54(6): 913-21, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23564760